尿中白血素E4用于预测患有性综合征的儿童的类固醇敏感性:一项观察性队列研究
Nehal Saad1, Amal Osman2, Mostafa Mansour3
1Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, 35511, Egypt.
Pediatric nephrology (Berlin, Germany)
|October 1, 2025
概括
尿液中的白血素E4 (LTE4) 水平在患有性综合征 (NS) 的儿童中升高,但不能预测类固醇反应. 需要进一步的研究来理解LTE4.
科学领域:
- 儿科脏病学 儿科脏病学
- 生物标志物发现发现
- 炎症调解者 炎症调解者
背景情况:
- 性综合征 (NS) 是一种常见的儿科脏疾病.
- 胰岛素蛋白 (LTs) 是炎症调解剂,与NS病变发生有关.
- 尿中的白血素E4 (LTE4) 被评估为一种潜在的生物标志物.
研究的目的:
- 测量新发性NS的儿童尿液LTE4水平.
- 评估LTE4作为儿童NS中类固醇反应的生物标志物.
主要方法:
- 对41名患有NS的儿童和41名对照进行了观察性队列研究.
- 在治疗前通过ELISA测量尿液LTE4.
- 患者被分为类固醇敏感 (SSNS) 和类固醇耐药 (SRNS) 组.
主要成果:
- 在NS患者和对照人群中,尿液LTE4水平显著更高.
- 在LTE4和蛋白尿或白蛋白水平之间没有发现显著的相关性.
- 尿液LTE4在SSNS和SRNS组之间没有差异;对于类固醇反应的预测值很差.
结论:
- 在儿科NS中尿路LTE4升高并不能可靠地预测类固醇敏感性.
- 作为NS中类固醇反应的预测生物标志物,LTE4的作用有限.
- 未来的研究应该调查血和尿液中的白血蛋白样本.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Nephrotic Syndrome II : Assessment and Medical Management
201
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
201
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Nephrotic Syndrome III : Nursing Management
282
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
282
Nephrotic Syndrome I : Introduction
502
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
502
Urine Studies II: Urine Culture and Sensitivity Test
860
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
860


